Nationwide Law Firm Looks Beyond the Bottom Line to Help Clients with Permanent Alopecia due to Cancer Drug Taxotere

PHOENIX - Feb. 1, 2017 - PRLog -- Arentz Law Group (ALG) now represents 1,000 women who may have suffered permanent hair loss as a result of the chemotherapy drug, Taxotere (Docetaxel). Given that this litigation is still in its infancy, this number is substantial for any one law firm, but ALG isn't any one law firm. They work with a variety of firms throughout the U.S. to pair clients with the best law firms for their case so that all legitimate claims have a better chance of seeing their day in court and being heard.

"Many injured parties with legitimate claims will give up on the legal process after a law firm does not accept their case. They have a false belief that a firm's decision is a reflection of the merits of their claim. Criteria for case selection can vary widely between firms based on a number of factors, this makes it difficult for clients to randomly select the right firm for their particular case," Robert Arentz, founder of ALG, said. "We have partnered up with some of the best law firms in the United States to make sure that injured individuals with valid claims get the compensation they deserve."

When clients call Arentz Law Group, they are asked to provide as much information as possible to pair them with the best possible law firm for their case. Arentz Law Group helps with all of the paperwork, questions, and concerns throughout the entire process, while their partner firms gets to work on expediting and strengthening clients' claims as much as possible. This means that clients get access to all of Arentz Law Group's resources and support as well as that of their partner firms. Like most other personal injury law firms, ALG doesn't get paid unless clients do. Through a process called fee splitting, Arentz Law Group's fee is built into its partner firms' existing percentage structure; in this way clients are able to benefit from the resources and expertise of both firms at no additional cost.

Arentz Law Group is currently pursuing claims against the makers of the cancer drug Taxotere. While Taxotere is used in the treatment of many types of cancer, at this time the litigation primarily involves women who received the chemotherapy drug as treatment for breast cancer. Plaintiffs allege that Taxotere developer Sanofi-Aventis encouraged doctors to use Taxotere instead of the equally effective drug, Taxol (Paclitaxel), but failed to warn doctors and patients about the connection between permanent hair loss and Taxotere. Sanofi-Aventis has known about this side effect for more than a decade and updated warning labels to include permanent hair loss in Canada and Europe in 2005 and 2012 respectively. U.S. warning labels were only updated by the manufacturer in late 2015. Many plaintiffs allege that they could have used a different chemotherapy drug if they had been warned about the permanent alopecia risk associated with Taxotere as there were alternative treatments available, including Tecentriq (Atezolizumab), which has fewer side effects and was found to have a higher survival rate than Taxotere in treating cancer.

Individuals who have experienced permanent hair loss after receiving Taxotere treatments for cancer may be entitled to significant compensation from the pharmaceutical company for their failure to warn. Those wishing to file a caim, or who would like more information about Taxotere or other defective drug or product lawsuit, are encouraged to call (800) 305-6000 or visit arentzlaw.com.

Arentz Law Group, P.C., is a premiere national personal injury law firm, helping victims from across the U.S. obtain justice and compensation from all types of negligent parties, including pharmaceutical companies and medical device manufacturers. They work with clients to make what can be an intimidating and complex process as easy and comfortable as possible so that clients can work on recovery and getting back to the business of life. ALG and its partner law firms have recovered more than $1 billion dollars in settlements and verdicts on behalf of injured consumers.